BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27462006)

  • 1. In vitro stereoselective inhibition of ginsenosides toward UDP-glucuronosyltransferase (UGT) isoforms.
    Kim D; Zheng YF; Min JS; Park JB; Bae SH; Yoon KD; Chin YW; Oh E; Bae SK
    Toxicol Lett; 2016 Sep; 259():1-10. PubMed ID: 27462006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside Rc Is a New Selective UGT1A9 Inhibitor in Human Liver Microsomes and Recombinant Human UGT Isoforms.
    Lee H; Heo JK; Lee GH; Park SY; Jang SN; Kim HJ; Kwon MJ; Song IS; Liu KH
    Drug Metab Dispos; 2019 Dec; 47(12):1372-1379. PubMed ID: 31578207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the in vitro/in vivo drug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition.
    Zheng YF; Bae SH; Choi EJ; Park JB; Kim SO; Jang MJ; Park GH; Shin WG; Oh E; Bae SK
    Food Chem Toxicol; 2014 Jun; 68():117-27. PubMed ID: 24632066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-inhibition relationship of ginsenosides towards UDP-glucuronosyltransferases (UGTs).
    Fang ZZ; Cao YF; Hu CM; Hong M; Sun XY; Ge GB; Liu Y; Zhang YY; Yang L; Sun HZ
    Toxicol Appl Pharmacol; 2013 Mar; 267(2):149-54. PubMed ID: 23306165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted screen for human UDP-glucuronosyltransferases inhibitors and the evaluation of potential drug-drug interactions with zafirlukast.
    Oda S; Fujiwara R; Kutsuno Y; Fukami T; Itoh T; Yokoi T; Nakajima M
    Drug Metab Dispos; 2015 Jun; 43(6):812-8. PubMed ID: 25834030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
    Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
    Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin is an effective modifier of multiple UDP-glucuronosyltransferase enzymes: evaluation of its potential to alter the pharmacokinetics of zidovudine.
    Sun H; Zhang T; Wu Z; Wu B
    J Pharm Sci; 2015 Jan; 104(1):244-56. PubMed ID: 25393417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the inhibition potential of Licochalcone A against human UDP-glucuronosyltransferases.
    Xin H; Qi XY; Wu JJ; Wang XX; Li Y; Hong JY; He W; Xu W; Ge GB; Yang L
    Food Chem Toxicol; 2016 Apr; 90():112-22. PubMed ID: 26875642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in silico evaluation of stereoselective effect of ginsenoside isomers on platelet P2Y
    Yang Q; Wang N; Zhang J; Chen G; Xu H; Meng Q; Du Y; Yang X; Fan H
    Phytomedicine; 2019 Nov; 64():152899. PubMed ID: 31454649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human UDP-glucuronosyltransferase, UGT1A8, glucuronidates dihydrotestosterone to a monoglucuronide and further to a structurally novel diglucuronide.
    Murai T; Samata N; Iwabuchi H; Ikeda T
    Drug Metab Dispos; 2006 Jul; 34(7):1102-8. PubMed ID: 16595710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and Comparison of the Inhibition Effect of Astragaloside IV and Aglycone Cycloastragenol on Various UDP-Glucuronosyltransferase (UGT) Isoforms.
    Ran R; Zhang C; Li R; Chen B; Zhang W; Zhao Z; Fu Z; Du Z; Du X; Yang X; Fang Z
    Molecules; 2016 Nov; 21(12):. PubMed ID: 27916843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
    Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
    Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The different metabolism of morusin in various species and its potent inhibition against UDP-glucuronosyltransferase (UGT) and cytochrome p450 (CYP450) enzymes.
    Shi X; Yang S; Zhang G; Song Y; Su D; Liu Y; Guo F; Shan L; Cai J
    Xenobiotica; 2016; 46(5):467-76. PubMed ID: 26372370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between oblongifolin C and UDP-glucuronosyltransferase isoforms in human liver and intestine microsomes.
    Gao C; Shi R; Wang T; Tan H; Xu H; Ma Y
    Xenobiotica; 2015; 45(7):578-85. PubMed ID: 25714435
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Jang SN; Park SY; Lee H; Jeong H; Jeon JH; Song IS; Kwon MJ; Liu KH
    Xenobiotica; 2021 Oct; 51(10):1087-1094. PubMed ID: 34338601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoselective glucuronidation of propranolol in human and cynomolgus monkey liver microsomes: role of human hepatic UDP-glucuronosyltransferase isoforms, UGT1A9, UGT2B4 and UGT2B7.
    Hanioka N; Hayashi K; Shimizudani T; Nagaoka K; Koeda A; Naito S; Narimatsu S
    Pharmacology; 2008; 82(4):293-303. PubMed ID: 18936551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitory effect of 20(S)-protopanaxatriol (ppt) towards UGT1A1 and UGT2B7.
    He YJ; Fang ZZ; Ge GB; Jiang P; Jin HZ; Zhang WD; Yang L
    Phytother Res; 2013 Apr; 27(4):628-32. PubMed ID: 22736593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of UDP-glucuronosyltransferase (UGT)-mediated glycyrrhetinic acid 3-O-glucuronidation by polyphenols and triterpenoids.
    Koyama M; Shirahata T; Hirashima R; Kobayashi Y; Itoh T; Fujiwara R
    Drug Metab Pharmacokinet; 2017 Aug; 32(4):218-223. PubMed ID: 28754329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two ginseng UDP-glycosyltransferases synthesize ginsenoside Rg3 and Rd.
    Jung SC; Kim W; Park SC; Jeong J; Park MK; Lim S; Lee Y; Im WT; Lee JH; Choi G; Kim SC
    Plant Cell Physiol; 2014 Dec; 55(12):2177-88. PubMed ID: 25320211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.
    Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T
    Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.